Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elaprase in MPS II (Hunter Syndrome)
NCT00069641Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2003
- Primary completion
- Mar 2005
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Sep 2003; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT00069641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069641.